Massachusetts General Hospital: Cardiovascular Diseases trials

The registry lists 27 Cardiovascular Diseases studies with Massachusetts General Hospital as lead sponsor. 6 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 2 5Phase 3 2Phase 4 1No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Reducing Arterial Inflammation Using Eplerenone and Statins in HIVNot yet recruitingNCT07892664Phase 2/3
• Multi-organ Imaging of Microvascular and Metabolic FunctionNot yet recruitingNCT07604207Early Phase 1
• Determining the Benefits of Exercise on Cardiovascular Risk in PTSDRecruitingNCT07260032Not applicable
• EVOC - EVs in Obesity and Cardiometabolic DiseaseRecruitingNCT06408961
• Study to Determine the Clinical Significance of Intravascular OCT-NIRAFEnrolling by invitationNCT06374498Not applicable
• Mindfulness and Behavior Change to Improve Cardiovascular Health of Older People With HIVRecruitingNCT06001814Not applicable
• MBCT Via Group Videoconferencing for Acute Coronary Syndrome Patients With Depressive Symptoms: A Pilot RCTCompletedNCT04799899Not applicableResults posted
• The ENCHANTMENT HIV StudyCompletedNCT04153136Phase 2Results posted
• A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease RiskCompletedNCT03416920Not applicableResults posted
• Healthy Hearts Healthy MindsCompletedNCT03373110Not applicableResults posted
• Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study)CompletedNCT02740179Not applicableResults posted
• Statin Therapy to Improve Atherosclerosis in HIV PatientsCompletedNCT00965185Not applicableResults posted
• Impact of Cognitive Behavioral Therapy on PTSD-CVD LinkCompletedNCT06429293Not applicable
• Immunomodulatory Effects of PCSK9 InhibitionWithdrawnNCT05720156
• Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19Status unknownNCT04377997Phase 2
• Effects of Gender-Affirming Hormone Therapy Among Transgender WomenCompletedNCT04128488
• Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical PatientsWithdrawnNCT04022161Phase 2
• Effects of Nitric Oxide on the Endothelium During Hemolysis.WithdrawnNCT03748082Phase 2
• Implementation of a Population Health Chronic Disease Management ProgramCompletedNCT02812303
• Ugandan Non-Communicable Diseases and Aging CohortCompletedNCT02445079
• A Randomized Controlled Trial of a Video Decision Aid in the ICUStatus unknownNCT01776333Not applicable
• Impact of Vitamin D Supplementation on Cardiac Structure and FunctionCompletedNCT01630213Not applicable
• The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular DiseasesCompletedNCT00842868
• HIV and Cardiovascular RiskCompletedNCT00465426
• Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate CancerCompletedNCT00455624
• Bupropion for Hospitalized Smokers With Acute Cardiovascular DiseaseCompletedNCT00181818Phase 4
• Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)CompletedNCT00000517Phase 3